Characterisation of C101248: A novel selective THIK-1 channel inhibitor for the modulation of microglial NLRP3-inflammasome. (2023)
Attributed to:
New insights into NLRP3 within inflammatory disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.neuropharm.2022.109330
PubMed Identifier: 36375694
Publication URI: http://europepmc.org/abstract/MED/36375694
Type: Journal Article/Review
Volume: 224
Parent Publication: Neuropharmacology
ISSN: 0028-3908